In this study, methylation of ESR1, which had been previously detected in grade II and grade III oligodendrogliomas but whose clinical correlation with prognosis had not been previously examined 18, was found to be a statistically significant predictor of overall and progression‐free survival using univariate survival analysis. The gene discussed is ESR1; the disease is oligodendroglioma.